3,5-diiodothyronine, (l)-isomer and 3,3',5-triiodothyroacetic acid

3,5-diiodothyronine, (l)-isomer has been researched along with 3,3',5-triiodothyroacetic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Actis, M; Evison, B; Fujii, N; Inoue, A; Perry, S; Punchihewa, C1
Arifi, S; Bischoff, I; Chaikuad, A; Fürst, R; Gellrich, L; Goebel, T; Heering, J; Heitel, P; Kahnt, A; Kilu, W; Knapp, S; Merk, D; Paulke, A; Pogoda, W; Pollinger, J; Proschak, E; Schubert-Zsilavecz, M; Steinhilber, D; Wurglics, M1

Other Studies

2 other study(ies) available for 3,5-diiodothyronine, (l)-isomer and 3,3',5-triiodothyroacetic acid

ArticleYear
Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis.
    Bioorganic & medicinal chemistry, 2013, Apr-01, Volume: 21, Issue:7

    Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA; DNA Damage; DNA Replication; HeLa Cells; Humans; Neoplasms; Proliferating Cell Nuclear Antigen; Protein Interaction Maps; Small Molecule Libraries; Structure-Activity Relationship

2013
l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ.
    Journal of medicinal chemistry, 2020, 07-09, Volume: 63, Issue:13

    Topics: Amino Acid Sequence; Animals; Drug Evaluation, Preclinical; Male; Mice; Models, Molecular; PPAR gamma; Protein Conformation; Thyroxine

2020